Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Neurochemistry

• Publication date

  1996-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.1996.67020880.xPMID 8764620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated byβ protein immunostain

  2004cited by this paper
• Characterization of apolipoprotein J-Alzheimer's A beta interaction.

  1995cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome

  1995cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.

  1994cited by this paper
• Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

  1994cited by this paper
• The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.

  1994cited by this paper
• The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

  1993cited by this paper
• Characterization of beta-amyloid peptide from human cerebrospinal fluid.

  1993cited by this paper
• Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

  1993cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Technique-dependent variations in cerebral microvessel blood volumes and hematocrits in the rat.

  1992cited by this paper
• Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis.

  1991cited by this paper
• Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum.

  1990cited by this paper
• Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.

  1989cited by this paper
• Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact.

  1988cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper
• Intracellular neurofibrillary tangle-like aggregations. A constantly present amyloid alteration in the aging choroid plexus.

  1986cited by this paper
• Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space.

  1985cited by this paper
• Distribution of two model amino acids from cerebrospinal fluid to brain and blood.

  1982cited by this paper
• Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.

  1975cited by this paper
• Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion.

  1975cited by this paper

• Synthesized boron compounds: Neurotoxic and oxidative effects in an in vitro model of Alzheimer's disease

  2025cites this paper
• Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets

  2025cites this paper
• Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-β.

  2025cites this paper
• Association between idiopathic normal pressure hydrocephalus and Alzheimer's disease: a bidirectional Mendelian randomization study

  2024cites this paper
• Arachnoid granulations: Dynamic nature and review.

  2024cites this paper
• Understanding the Liver’s Role in the Clearance of Aβ40

  2024cites this paper
• House dust mite-induced asthma exacerbates Alzheimer’s disease changes in the brain of the AppNL-G-F mouse model of disease

  2024cites this paper
• Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems

  2024cites this paper
• Role of Human Serum Albumin in the Prevention and Treatment of Alzheimer’s Disease

  2024cites this paper
• Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases

  2023cites this paper
• The role of human serum albumin in prevention and treatment of Alzheimer’s disease

  2023cites this paper
• Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease

  2022cites this paper
• The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans

  2022cites this paper
• The glymphatic hypothesis: the theory and the evidence

  2022cites this paper
• Gut Microbiota and Immunotherapy for Alzheimer’s Disease

  2022cites this paper
• Evaluation of Blood-CSF Barrier Transport by Quantitative Real Time Fluorescence Microscopy

  2022cites this paper
• Cognitive Disorders and Oxidative Stress Status Attenuated by Chrysophyllum Perpulchrum Extract in Alzheimer- like Rat Model of Intracerebroventricular Aβ1-40 injection

  2021cites this paper
• Neuroinflammation and its resolution in Alzheimer's disease

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021cites this paper
• Harnessing Cerebrospinal Fluid Circulation for Drug Delivery to Brain Tissues.

  2021cites this paper
• Human Amyloid- b 40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo s

  2020cites this paper
• Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer’s Disease?

  2020cites this paper
• Human Amyloid-β40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo

  2020cites this paper
• Is the p3 (A β 17–40, A β 17–42) peptide relevant to the pathology of Alzheimer’s Disease?

  2020cites this paper
• Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

  2020cites this paper
• Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice

  2019cites this paper
• Obstructive sleep apnea may increase the risk of Alzheimer's disease

  2019cites this paper
• Anatomy and Physiology of Cerebrospinal Fluid Dynamics

  2019cites this paper
• Plasma Rich in Growth Factors (PRGF) Disrupt the Blood-Brain Barrier Integrity and Elevate Amyloid Pathology in the Brains of 5XFAD Mice

  2019cites this paper
• Current strategies for therapeutic drug delivery after traumatic CNS injury.

  2019cites this paper
• Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer’s Disease

  2018cites this paper
• Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease

  2018cites this paper
• The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system?

  2018cites this paper
• Recent Insights on Alzheimer’s Disease Originating from Yeast Models

  2018cites this paper
• Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

  2018cites this paper
• An amylin analog used as a challenge test for Alzheimer's disease

  2017cites this paper
• TREM1: A Potential Therapeutic Target For Alzheimer’s Disease

  2017cites this paper
• Influence of physical exercise on β-amyloid, α-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells.

  2017cites this paper
• α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects

  2017cites this paper
• A blood-based signature of neocortical amyloid burden : an early diagnostic population screening tool for Alzheimer's disease

  2017cites this paper
• The Glymphatic Pathway: Waste Removal from the CNS via Cerebrospinal Fluid Transport

  2017cites this paper
• The Blood-Brain Barriers

  2017cites this paper
• Biochemical signature in Alzheimer’s disease

  2017cites this paper
• A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain

  2017cites this paper
• Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery

  2017influential citation
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.

  2017cites this paper
• Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial

  2016cites this paper
• Serotonin system in Alzheimer's disease : from a molecular and biomarkers perspective

  2016influential citation
• Modulating Role of TTR in Aβ Toxicity, from Health to Disease

  2016cites this paper
• A Surgical Method to Improve the Homeostasis of CSF for the Treatment of Alzheimer’s Disease

  2016cites this paper
• Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.

  2016cites this paper
• In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein

  2016cites this paper
• Plasma Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men

  2016cites this paper
• Genetic, Biochemical and Cellular Correlates Associated with Alzheimer’s Disease

  2016cites this paper
• Antibody modified-silver nanoparticles for colorimetric immuno sensing of Aβ(1–40/1–42) based on the interaction between β-amyloid and Cu2+

  2016cites this paper
• Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System

  2016cites this paper
• The Choroid Plexus and Cerebrospinal Fluid System: Roles in Neurodegenerative Diseases

  2016cites this paper
• Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome

  2015cites this paper
• Normal Pressure Hydrocephalus: Etiology, Diagnosis, Treatment, and Putative Nutritional and Lifestyle Risk Factors

  2015cites this paper
• Changes in the cerebrospinal fluid circulatory system of the developing rat: quantitative volumetric analysis and effect on blood-CSF permeability interpretation

  2015cites this paper
• A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer’s brain, CSF and plasma

  2015cites this paper
• Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology

  2015cites this paper
• Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Pharmacokinetics and Bioavailability of a Therapeutic Enzyme (Idursulfase) in Cynomolgus Monkeys after Intrathecal and Intravenous Administration

  2015cites this paper
• Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer’s disease

  2015cites this paper
• The quest for a better insight into physiology of fluids and barriers of the brain: the exemplary career of Joseph D. Fenstermacher

  2015cites this paper
• Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs

  2014cites this paper
• Blood Platelets in the Progression of Alzheimer’s Disease

  2014cites this paper
• Intrathecal delivery of protein therapeutics to the brain: a critical reassessment.

  2014cites this paper
• A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly

  2014cites this paper
• Interactions between Apo E and amyloid beta and their relationship to nutriproteomics and neurodegeneration

  2014cites this paper
• Potensi Terapi Hormon Testosteron terhadap Ekspresi β Amyloid pada Marmut sebagai Model Penyakit Alzheimer

  2014cites this paper
• Plasma insulin-degrading enzyme: Characterisation and evaluation as a potential biomarker for Alzheimer's disease

  2014cites this paper
• Amyloid‐β efflux from the central nervous system into the plasma

  2014cites this paper
• Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review

  2013cites this paper
• Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging

  2013cites this paper
• Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders

  2013cites this paper
• Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain

  2013cites this paper
• Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.

  2013cites this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cites this paper
• DEVELOPMENT OF BUTYRYLCHOLINESTERASE LIGANDS FOR THE IMAGING OF NEUROLOGICAL DISORDERS

  2013cites this paper
• Importance of Peptide Transporter 2 on the Cerebrospinal Fluid Efflux Kinetics of Glycylsarcosine Characterized by Nonlinear Mixed Effects Modeling

  2013cites this paper
• Enhanced Proteolytic Clearance of Plasma Aβ by Peripherally Administered Neprilysin Does Not Result in Reduced Levels of Brain Aβ in Mice

  2013cites this paper
• Efflux of Human and Mouse Amyloid ß Proteins 1-40 and 1-42 From Brain: Impairment in a Mouse Model of Alzheimer's Disease

  2012cites this paper
• The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.

  2012cites this paper
• INVESTIGATIONS OF OXIDATIVE STRESS EFFECTS AND THEIR MECHANISMS IN RAT BRAIN AFTER SYSTEMIC ADMINISTRATION OF CERIA ENGINEERED NANOMATERIALS

  2012cites this paper
• Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer disease.

  2012cites this paper
• Cerebrospinal Fluid β-Amyloid Turnover in the Mouse, Dog, Monkey and Human Evaluated by Systematic Quantitative Analyses

  2012cites this paper
• Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

  2012cites this paper
• Brain meets body: the blood-brain barrier as an endocrine interface.

  2012cites this paper
• Rôle du système plexus choroïde-liquide céphalorachidien dans la distribution des cellules immunes au sein du système nerveux central, exemple de l’encéphalomyélite auto-immune expérimentale

  2012cites this paper
• Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood

  2012cites this paper
• Amyloid β Levels in Human Red Blood Cells

  2012cites this paper
• Cerebral Amyloid Angiopathy: A Systematic Review

  2011cites this paper
• Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease

  2011cites this paper
• Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus

  2011cites this paper
• Invited Review Cerebrovascular amyloidosis: Experimental analysis in vitro and in vivo

  2011cites this paper
• Amyloid‐β peptide(1‐40) elimination from cerebrospinal fluid involves low‐density lipoprotein receptor‐related protein 1 at the blood‐cerebrospinal fluid barrier

  2011cites this paper
• Tight Junctions in Brain Barriers During Central Nervous System Inflammation

  2011cites this paper